AMBER CAMPBELL: Open Payments
NPI 1891247441 · ONTARIO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,957 in 175 payments from 30 companies in 2025. Trend: 2023 $2,476 · 2024 $3,333 · 2025 $2,957
Food & beverage: $2,957
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $720 |
| AstraZeneca Pharmaceuticals LP | 9 | $285 |
| Lundbeck LLC | 15 | $251 |
| Novo Nordisk Inc | 16 | $199 |
| Lilly USA, LLC | 14 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $161 |
| Astellas Pharma US Inc | 7 | $155 |
| GlaxoSmithKline, LLC. | 7 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| Axsome Therapeutics, Inc. | 5 | $86 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Veozah, UBRELVY, FARXIGA, QULIPTA, JARDIANCE.
Industry payments across OH — which companies pay providers there.
